Identifying autoantibody signatures in cancer: a promising challenge
暂无分享,去创建一个
[1] P. Rouanet,et al. Identification of a New Panel of Serum Autoantibodies Associated with the Presence of In situ Carcinoma of the Breast in Younger Women , 2009, Clinical Cancer Research.
[2] L. Dai,et al. Evaluation of Tumour‐Associated Antigen (TAA) Miniarray in Immunodiagnosis of Colon Cancer , 2009, Scandinavian journal of immunology.
[3] Eckart Meese,et al. Toward an early diagnosis of lung cancer: An autoantibody signature for squamous cell lung carcinoma , 2008, International journal of cancer.
[4] P. Rouanet,et al. Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ. , 2008, Journal of proteome research.
[5] Eckart Meese,et al. Pattern of Serum Autoantibodies Allows Accurate Distinction between a Tumor and Pathologies of the Same Organ , 2008, Clinical Cancer Research.
[6] Hans-Peter Lenhof,et al. Increased Seroreactivity to Glioma-Expressed Antigen 2 in Brain Tumor Patients under Radiation , 2008, PloS one.
[7] Y. Yen,et al. Autoantibodies as potential biomarkers for breast cancer , 2008, Breast Cancer Research.
[8] Lixin Sun,et al. Profiling Tumor-Associated Autoantibodies for the Detection of Colon Cancer , 2008, Clinical Cancer Research.
[9] Jianjun Yu,et al. Humoral Response Profiling Reveals Pathways to Prostate Cancer Progression*S , 2008, Molecular & Cellular Proteomics.
[10] Hailing Lu,et al. Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer. , 2008, Journal of proteome research.
[11] B. Ye,et al. Use of a Combination of Approaches to Identify and Validate Relevant Tumor-Associated Antigens and Their Corresponding Autoantibodies in Ovarian Cancer Patients , 2008, Clinical Cancer Research.
[12] David E. Misek,et al. Identification of 14-3-3θ as an antigen that induces a humoral response in lung cancer , 2007 .
[13] S. Drăghici,et al. Autoantibody Approach for Serum-Based Detection of Head and Neck Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.
[14] Gil Mor,et al. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays , 2007, Proceedings of the National Academy of Sciences.
[15] A Murray,et al. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure , 2007, Thorax.
[16] M. Caron,et al. Cancer Immunomics Using Autoantibody Signatures for Biomarker Discovery* , 2007, Molecular & Cellular Proteomics.
[17] Jhingook Kim,et al. Optimized serological isolation of lung-cancer-associated antigens from a yeast surface-expressed cDNA library. , 2007, Journal of microbiology and biotechnology.
[18] J. Robertson,et al. Autoantibodies in breast cancer: their use as an aid to early diagnosis. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[19] E. Diamandis,et al. High throughput proteomic strategies for identifying tumour-associated antigens. , 2007, Cancer letters.
[20] Fang Yang,et al. Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis. , 2007, Journal of proteome research.
[21] A. Admon,et al. Novel technologies for cancer biomarker discovery: humoral proteomics. , 2007, Cancer biomarkers : section A of Disease markers.
[22] Xuan Peng,et al. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. , 2007, Journal of hepatology.
[23] A. Shimizu,et al. Proteomics-Based Approach Identifying Autoantibody against Peroxiredoxin VI as a Novel Serum Marker in Esophageal Squamous Cell Carcinoma , 2006, Clinical Cancer Research.
[24] Ugur Sahin,et al. Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1. , 2006, Cancer letters.
[25] Weiliang Qiu,et al. Development of a “reverse capture” autoantibody microarray for studies of antigen‐autoantibody profiling , 2006, Proteomics.
[26] A. Butte,et al. Multiplexed protein array platforms for analysis of autoimmune diseases. , 2006, Annual review of immunology.
[27] Joshua R. Ehrlich,et al. The 'reverse capture' autoantibody microarray:a native antigen-based platform for autoantibody profiling , 2006, Nature Protocols.
[28] G. Michaud,et al. Biomarker discovery using protein microarray technology platforms: antibody-antigen complex profiling , 2005, Expert review of proteomics.
[29] U. Fischer,et al. Autoantibodies against GLEA2 and PHF3 in glioblastoma: Tumor‐associated autoantibodies correlated with prolonged survival , 2005, International journal of cancer.
[30] M. Pfreundschuh,et al. Serological identification of breast cancer‐related antigens from a Saccharomyces cerevisiae surface display library , 2005, International journal of cancer.
[31] O. Finn,et al. Immune response as a biomarker for cancer detection and a lot more. , 2005, The New England journal of medicine.
[32] Debashis Ghosh,et al. Autoantibody signatures in prostate cancer. , 2005, The New England journal of medicine.
[33] Christina Backes,et al. Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[34] Joshua LaBaer,et al. The sentinel within: exploiting the immune system for cancer biomarkers. , 2005, Journal of proteome research.
[35] R. Marouga,et al. The development of the DIGE system: 2D fluorescence difference gel analysis technology , 2005, Analytical and bioanalytical chemistry.
[36] T. Daniels,et al. Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor‐associated antigens , 2005, The Prostate.
[37] K. Hemminki,et al. p53 autoantibodies predict subsequent development of cancer , 2005, International journal of cancer.
[38] M. Dufva,et al. Diagnostic and analytical applications of protein microarrays , 2005, Expert review of proteomics.
[39] F. Shi,et al. Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection. , 2005, Cancer detection and prevention.
[40] Xiaoju Wang,et al. Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer , 2004, Cancer Research.
[41] E. Smeland,et al. NY‐ESO‐1 protein expression and humoral immune responses in prostate cancer , 2004, The Prostate.
[42] M. Mottolese,et al. Human mena protein, a serex‐defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T‐cell immune response , 2004, International journal of cancer.
[43] A. Stromberg,et al. Identification of circulating antibodies to tumor‐associated proteins for combined use as markers of non‐small cell lung cancer , 2004, Proteomics.
[44] David E. Misek,et al. Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. , 2004, Journal of proteome research.
[45] R. Chaby,et al. Positive Selection of B Cells Expressing Low Densities of Self-reactive BCRs , 2004, The Journal of experimental medicine.
[46] Cecelia E Schmalbach,et al. Molecular profiling of the immune response in colon cancer using protein microarrays: Occurrence of autoantibodies to ubiquitin C‐terminal hydrolase L3 , 2003, Proteomics.
[47] James A Koziol,et al. Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[48] M. Nussenzweig,et al. Predominant Autoantibody Production by Early Human B Cell Precursors , 2003, Science.
[49] A. Pinchera,et al. Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1. , 2003, The Journal of clinical endocrinology and metabolism.
[50] J. Koziol,et al. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[51] Y. Bang,et al. Identification and characterization of a novel cancer/testis antigen gene CAGE-1. , 2003, Biochimica et biophysica acta.
[52] E. B. Butler,et al. Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers , 2003, Proteomics.
[53] S. Hanash. Harnessing immunity for cancer marker discovery , 2003, Nature Biotechnology.
[54] B. Seliger,et al. Design of proteome‐based studies in combination with serology for the identification of biomarkers and novel targets , 2002, Proteomics.
[55] P. Brown,et al. Autoantigen microarrays for multiplex characterization of autoantibody responses , 2002, Nature Medicine.
[56] H. Ditzel,et al. The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[57] K. Zatloukal,et al. Identification of tumor antigens in renal cell carcinoma by serological proteome analysis , 2001, Proteomics.
[58] Dieter Stoll,et al. A microarray enzyme‐linked immunosorbent assay for autoimmune diagnostics , 2000, Electrophoresis.
[59] D. Jäger,et al. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene. , 1999, Cancer research.
[60] Lloyd J. Old,et al. A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens , 1998, The Journal of experimental medicine.
[61] M. Pfreundschuh,et al. Serological identification of human tumor antigens. , 1997, Current opinion in immunology.
[62] Eric T. Boder,et al. Yeast surface display for screening combinatorial polypeptide libraries , 1997, Nature Biotechnology.
[63] Yao-Tseng Chen,et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[64] T. Soussi,et al. Serum p53 antibodies as early markers of lung cancer , 1995, Nature Medicine.
[65] S. P. Fodor,et al. Light-directed, spatially addressable parallel chemical synthesis. , 1991, Science.
[66] R. Ekins,et al. Multi-analyte immunoassay. , 1989, Journal of pharmaceutical and biomedical analysis.
[67] H. Barrett,et al. 1 – The Clinical Setting , 1981 .
[68] Baldwin Rw. Tumour-associated antigens and tumour-host interactions. , 1971 .
[69] Baldwin Rw. An immunological approach to cancer. , 1968 .
[70] R. W. Baldwin. Tumour‐specific immunity against spontneous rat tumours , 1966, International journal of cancer.